Boxer Capital, LLC Passage Bio, Inc. Transaction History

Boxer Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.24 - $10.2 $12 Million - $19.7 Million	-1,928,315 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$14.59 - $36.07 $656,550 - $1.62 Million	45,000 Added 2.39%	1,928,315 $52.7 Million
Q1 2020 May 15, 2020	BUY	$8.86 - $22.2 $16.7 Million - $41.8 Million	1,883,315 New	1,883,315 $29.7 Million

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $28.3M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.